Skip to main content
PROVEXIS PLC logo

PROVEXIS PLC — Investor Relations & Filings

Ticker · PXS ISIN · GB00B0923P27 LEI · 21380042E3Y3N9VZ6N48 IL Professional, scientific and technical activities
Open in API
Filings indexed 207 across all filing types
Latest filing 2013-09-16 Share Issue/Capital Cha…
Country GB United Kingdom
Listing IL PXS

About PROVEXIS PLC

https://www.provexis.org/

Provexis PLC is a life sciences company that develops, licenses, and commercializes functional ingredients for the global food, beverage, and dietary supplement markets. The company's principal technology is Fruitflow®, a patented, scientifically-proven bioactive ingredient derived from tomatoes. Fruitflow® is designed to support cardiovascular health by helping to maintain normal blood platelet aggregation, which contributes to healthy blood flow. Provexis licenses its technology to business partners for inclusion in their consumer products.

Recent filings

Filing Released Lang Actions
Price Monitoring Extension
Share Issue/Capital Change Classification · 99% confidence The document is very short (1185 characters) and announces a specific, non-financial operational event: a 'Price Monitoring Extension' for a security's closing auction call on the London Stock Exchange. It explicitly states, 'This information is provided by RNS The company news service from the London Stock Exchange'. This structure strongly suggests a general regulatory announcement that doesn't fit the specific financial report categories (like 10-K, ER, IR, etc.). Therefore, the most appropriate classification is the general regulatory fallback category, RNS.
2013-09-16 English
Draw Down of Funds and Issue of Equity
Capital/Financing Update Classification · 99% confidence The document begins with an 'RNS Number' and is dated 11 September 2013. The content details a 'Draw Down of Funds, Issue of Equity and Renewal of £10 million Equity Financing Facility'. This involves the allotment and issuance of new ordinary shares and the establishment of a new financing agreement. This clearly falls under corporate financing and capital structure changes. The presence of the RNS identifier and the nature of the announcement (a specific corporate action update) strongly suggests a regulatory filing. Since the core topic is capital raising and financing facility renewal, the most specific code is 'CAP' (Capital/Financing Update). Although it is distributed via RNS, 'CAP' is more precise than the general 'RNS' fallback.
2013-09-11 English
Notice of AGM
AGM Information Classification · 98% confidence The document explicitly states 'RNS Number' and 'Notice of Annual General Meeting'. It announces that the AGM notice has been posted to shareholders and provides the date, time, and location of the AGM. Since this is an announcement about the AGM and the notice itself, it aligns best with the AGM Information category (AGM-R). Although it is an announcement, the content is specifically about the AGM proceedings rather than just announcing the publication of a report (which would lean towards RPA/RNS). Given the specific mention of the AGM details, AGM-R is the most precise fit.
2013-09-06 English
Group of companies' accounts made up to 2013-03-31
Regulatory Filings
2013-08-29 English
Demerger Effective
Regulatory Filings Classification · 99% confidence The document is explicitly marked with an 'RNS Number' and concludes with 'This information is provided by RNS The company news service from the London Stock Exchange'. The content announces that a 'Demerger has today become effective' and details the resulting share distribution and admission to AIM for the new entity, Science in Sport plc. This is a general, time-sensitive corporate announcement distributed via the London Stock Exchange's regulatory news service. Since it is a general regulatory announcement that doesn't fit specific categories like Capital Change (SHA) or M&A (TAR), the most appropriate classification is the general regulatory filing category, RNS.
2013-08-08 English
Second Price Monitoring Extn
Regulatory Filings Classification · 99% confidence The document is very short (1224 characters) and announces a 'Second Price Monitoring Extension' related to trading activity on the London Stock Exchange, identified by the 'RNS Number : 9943K'. It describes an extension of the closing auction call period due to price volatility. This is a general regulatory announcement concerning trading mechanics rather than a specific financial report (like 10-K, IR, or ER) or a specific corporate action (like DIV or DIRS). Given its nature as a general market notice provided by RNS, the most appropriate classification is the general regulatory filing fallback category.
2013-08-05 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.